Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc. (MMC) Market Cap

Marsh & McLennan Companies, Inc. has a market capitalization of $89.82B.

Price: $182.70

-2.93 (-1.58%)

Market Cap: 89.82B

NYSE · time unavailable

CEO: John Quinlan Doyle

Sector: Financial Services

Industry: Insurance - Brokers

IPO Date: 1987-12-30

Website: https://www.mmc.com

Marsh & McLennan Companies, Inc. (MMC) - Company Information

Market Cap: 89.82B|Sector: Financial Services

Company Profile

Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, catastrophe and financial modeling, and related advisory services; and insurance program management services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth, and career consulting services and products; and specialized management, as well as economic and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Analyst Sentiment

62%
Buy

From 23 Active Polls

1Y Forecast: $207.71

▲ +13.7% Potential Upside

Consensus Target Metrics

Low Bound

$190

Median

$208

High Bound

$236

Average

$208

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$207.71
▲ +13.69% Upside
Low Target
$190.00
4% Risk
Median Target
$208.00
14% Mid
High Target
$236.00
29% Max
Consensus
Hold
8 / 26 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)89,82083,95090,34898,951107,571120,063104,506109,760103,443
Enterprise Value ($M)100,548104,790109,110117,866127,504140,878123,970122,741117,225
Price to Earnings Ratio (P/E)20.4018.3127.5133.1222.2121.7333.1636.7322.99
Price/Earnings-to-Growth Ratio (PEG)1.217.161.335.11
Price to Sales Ratio (P/S)2.9011.0513.7015.5815.4217.0017.2319.2716.63
Price to Book Ratio (P/B)5.505.765.986.536.828.547.838.027.74
Price to Free Cash Flow Ratio (P/FCF)16.17-111.9343.9449.2366.73-177.3555.5959.6891.14
Enterprise Value to Sales (EV/Sales)13.7916.5418.5618.2819.9520.4321.5418.84
Enterprise Value to EBITDA (EV/EBITDA)15.0666.2872.5080.1360.1461.2886.0389.6661.79
Debt to Equity Ratio3.121.541.421.411.371.591.641.081.15

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 MARSH & MCLENNAN INC (MMC) — Investment Overview

🧩 Business Model Overview

Marsh & McLennan operates primarily as an insurance broker and risk advisor. It intermediates between corporate clients and insurance carriers—translating business risk into market-facing insurance placements, structuring coverage, negotiating terms, and supporting claims and policy administration. Beyond brokerage, the firm provides advisory services (risk consulting), employee benefits/retirement solutions, and analytics-enabled placement and servicing workflows.

The practical “how it works” is relationship-driven: MMC embeds into client risk management processes, builds insurer-market access and knowledge of coverage terms, and then delivers ongoing services across renewal cycles. Its value proposition is not only placement execution, but also ongoing refinement of risk programs and coverage documentation, which reduces friction for clients and lowers execution risk for complex corporate programs.

💰 Revenue Streams & Monetisation Model

  • Brokerage commissions tied to client premium volumes: The core revenue engine is compensation earned for arranging insurance. Commission rates and mix are influenced by market conditions, coverage complexity, and the distribution of business across lines and geographies.
  • Advisory and consulting fees: Risk consulting and benefits-related services are generally fee-based and tied to project scopes, program services, and ongoing administration.
  • Recurring policy servicing and client program management: Ongoing renewals and servicing activities create a repeatable revenue pattern, even when new sales are project-driven.

Margin structure is typically supported by a blend of (i) scale in broking and servicing workflows, (ii) higher-margin advisory work relative to pure placement, and (iii) cost discipline in professional and technology-enabled delivery. Operating leverage tends to improve when insurance-market activity and renewal volumes remain steady and advisory utilization stays healthy.

🧠 Competitive Advantages & Market Positioning

MMC’s moat is primarily driven by switching costs and intangible assets built through long-duration client relationships, proprietary know-how, insurer-market relationships, and the operational integration required to manage complex global programs.

  • Switching costs (client embeddedness): Replacing a broker is operationally disruptive—coverage is complex, claims history matters, policy language is nuanced, and internal stakeholders often rely on the broker’s established workflows and analytics. Renewal-cycle dependency reinforces stickiness.
  • Intangible assets (expertise and process): Deep line-of-business expertise, risk consulting methodologies, and disciplined placement execution reduce client execution risk and support tailored program design.
  • Scale in market access: Global reach and purchasing/placement capability improve access to carrier appetite and facilitate coverage optimization across geographies.

Competitive benchmarking:

  • Aon and Willis Towers Watson (major global peers) compete in insurance brokerage and risk/benefits advisory with similar client embeddedness and service depth.
  • Arthur J. Gallagher also competes meaningfully, particularly in mid-market and regional segments while expanding into broader advisory capabilities.

While rivals overlap across brokerage and advisory, MMC’s positioning emphasizes a broad platform across risk and benefits solutions and a global servicing model designed to retain clients through integrated, multi-service renewals—raising the cost (time, risk, and operational burden) of switching providers.

🚀 Multi-Year Growth Drivers

  • Secular demand for risk management and complex placement: Corporate exposures increasingly require sophisticated structuring (cyber, specialty lines, ESG-related risk considerations, and regulatory/operational risk). Brokerage and advisory capacity remain critical as underwriting complexity rises.
  • Benefits complexity and employer obligations: Employee benefits administration and retirement/health-related program complexity can sustain long-duration demand for specialized advisory and servicing.
  • Data-enabled placement and analytics adoption: As clients seek more transparency and performance measurement in insurance programs, advisory and analytics workflows can expand service intensity per client.
  • Market share capture through platform breadth: A large, integrated service platform can support cross-sell from brokerage into consulting and benefits-related solutions, subject to execution quality.

Over a 5–10 year horizon, growth is expected to be a function of (i) renewal-cycle volumes, (ii) service mix (advisory intensity), and (iii) platform penetration within existing clients—rather than reliance on any single line of business.

⚠ Risk Factors to Monitor

  • Insurance cycle sensitivity: Brokerage earnings can fluctuate with premium volume and market pricing dynamics across underwriting cycles.
  • Regulatory and compliance changes: Shifts in insurance distribution rules, broker compensation regulations, or benefits-related requirements can alter economics or operational processes.
  • Concentration with clients and carriers: While diversified, material contracts or carrier appetite changes can affect placement outcomes and profitability.
  • Operational and reputational risk: Errors in placement, claims advocacy, or advice quality can lead to client remediation costs, disputes, or brand damage.
  • Talent retention and productivity: High-quality advisory delivery is people-intensive; turnover in key client teams can pressure service continuity and margins.
  • Cyber and data security: The firm handles sensitive client information; security incidents can create direct costs and compliance exposure.

📊 Valuation & Market View

Equity markets commonly value brokerage and advisory franchises using earnings-based multiples and cash-flow durability frameworks, with additional attention to operating margin, service mix (advisory intensity), and resilience through underwriting cycles.

Key valuation sensitivities typically include:

  • Growth quality: Sustainable advancement in advisory/recurring service components versus pure placement volume.
  • Margin stability and operating leverage: Evidence of durable cost discipline and productivity.
  • Capital return capacity: Market expectations for buybacks/dividends aligned with cash generation.
  • Risk-adjusted earnings power: Reduced volatility from diversification across services and geographies.

🔍 Investment Takeaway

MMC is a high-quality global insurance broker and risk/benefits advisor with a durable moat grounded in switching costs and intangible service assets. The long-term thesis rests on persistent client demand for complex risk placement and advisory support, the stickiness of renewal-cycle relationships, and the ability to expand service intensity through analytics-enabled advisory and benefits expertise—tempered by insurance-cycle exposure and regulatory/compliance risk.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for MMC.

gurufocus.com2026-05-29

Medline's Prime Vendor model expands outside the United States

Medline's Prime Vendor model expands outside the United States PR Newswire NORTHFIELD, Ill., May 29, 2026

defenseworld.net2026-04-25

Calamos Advisors LLC Trims Stock Holdings in Marsh & McLennan Companies, Inc. $MRSH

Calamos Advisors LLC reduced its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 50.8% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 131,672 shares of the financial services provider's stock after selling 136,084 shares during the quarter.

defenseworld.net2026-04-25

Calamos Advisors LLC Has $24.43 Million Stake in Marsh & McLennan Companies, Inc. $MRSH

Calamos Advisors LLC reduced its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 50.8% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 131,672 shares of the financial services provider's stock after selling 136,084

defenseworld.net2026-04-20

Marsh & McLennan Companies, Inc. $MRSH Holdings Lowered by Private Trust Co. NA

Private Trust Co. NA trimmed its stake in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 80.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,863 shares of the financial services provider's stock after selling 11,853 shares during the

defenseworld.net2026-04-20

Private Trust Co. NA Lowers Stake in Marsh & McLennan Companies, Inc. $MRSH

Private Trust Co. NA lessened its stake in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 80.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,863 shares of the financial services provider's stock after selling 11,853 shares

defenseworld.net2026-04-18

Lbp Am Sa Buys New Stake in Marsh & McLennan Companies, Inc. $MRSH

Lbp Am Sa bought a new stake in Marsh and McLennan Companies, Inc. (NYSE: MRSH) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 28,840 shares of the financial services provider's stock, valued at approximately $5,350,000. A number of other hedge funds and other institutional investors

defenseworld.net2026-04-18

Marsh & McLennan Companies Q1 Earnings Call Highlights

Marsh and McLennan Companies (NYSE: MRSH) reported first-quarter 2026 results that management characterized as a "solid start" to the year, citing revenue growth, steady margins, and continued progress on its THRIVE efficiency program despite headwinds from lower fiduciary interest income and declining insurance and reinsurance pricing. Leadership changes and strategic focus On the call, President and

defenseworld.net2026-04-18

Marsh & McLennan Companies Q1 Earnings Call Highlights

Marsh and McLennan Companies (NYSE: MRSH) reported first-quarter 2026 results that management characterized as a "solid start" to the year, citing revenue growth, steady margins, and continued progress on its THRIVE efficiency program despite headwinds from lower fiduciary interest income and declining insurance and reinsurance pricing. Leadership changes and strategic focus On the call, President and

defenseworld.net2026-04-15

Marsh & McLennan Companies (NYSE:MRSH) Stock Price Down 6.2% on Analyst Downgrade

Marsh and McLennan Companies, Inc. (NYSE: MRSH - Get Free Report) traded down 6.2% on Monday after Bank of America lowered their price target on the stock from $181.00 to $174.00. Bank of America currently has an underperform rating on the stock. Marsh and McLennan Companies traded as low as $180.97 and last traded at $173.4670.

defenseworld.net2026-04-14

Baillie Gifford & Co. Increases Position in Marsh & McLennan Companies, Inc. $MRSH

Baillie Gifford and Co. lifted its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 5.8% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 87,167 shares of the financial services provider's stock after buying an additional 4,806 shares during the period. Baillie

defenseworld.net2026-04-14

Marsh & McLennan Companies, Inc. $MRSH Shares Acquired by Baillie Gifford & Co.

Baillie Gifford and Co. grew its holdings in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 5.8% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,167 shares of the financial services provider's stock after acquiring an

defenseworld.net2026-04-14

Deprince Race & Zollo Inc. Purchases 18,845 Shares of Marsh & McLennan Companies, Inc. $MRSH

Deprince Race and Zollo Inc. boosted its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 19.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 114,498 shares of the financial services provider's stock after purchasing an additional 18,845 shares

defenseworld.net2026-04-14

Deprince Race & Zollo Inc. Boosts Stock Position in Marsh & McLennan Companies, Inc. $MRSH

Deprince Race and Zollo Inc. raised its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 19.7% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 114,498 shares of the financial services provider's stock after purchasing an additional 18,845

defenseworld.net2026-04-11

Carnegie Investment Counsel Reduces Stock Position in Marsh & McLennan Companies, Inc. $MRSH

Carnegie Investment Counsel lowered its position in shares of Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 34.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,009 shares of the financial services provider's stock after selling 33,011 shares during the period.

defenseworld.net2026-04-11

Carnegie Investment Counsel Sells 33,011 Shares of Marsh & McLennan Companies, Inc. $MRSH

Carnegie Investment Counsel lessened its stake in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 34.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,009 shares of the financial services provider's stock after selling 33,011 shares during the period. Carnegie

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Most recent quarter (2026-03-31): Revenue $7.60B and net income $1.15B (EPS $2.37). QoQ, revenue rose to $7.60B from $6.60B (+15.2%), while net income jumped from $0.82B (+39.6%)—a clear sequential rebound. YoY, revenue increased from $7.06B (+7.7%), but net income declined from $1.38B (-17.0%) and EPS fell from $2.81 (-15.7%). Profitability is mixed over the 4-quarter span: net margin improved QoQ (about 12.4% in 2025-12 to ~15.1% in 2026-03), but remains below the year-ago level (net margin ~19.6% in 2025-03). This suggests better near-term cost/control versus the immediately prior quarter, but not a fully sustained earnings recovery YoY. Balance sheet resilience is broadly stable, with total assets roughly flat (~$58.5B) but equity down from $15.3B to $14.8B and net debt rising ($18.8B to $20.8B). MMC maintains a modest dividend (yield ~0.52% at 2026-03) with a payout ratio around 38%—generally supportive coverage. Shareholder returns: price-performance data was not provided, so total return assessment relies primarily on dividends and valuation improvement signals (P/E compressed to ~18.3 from ~27.5)."

Revenue Growth

Positive

Revenue improved strongly QoQ (+15.2% from 2025-12 to 2026-03) and was higher YoY (+7.7% vs 2025-03).

Profitability

Fair

Net income rose QoQ (+39.6%) and net margin improved (~12.4% to ~15.1%), but YoY profitability deteriorated: net income -17.0% and EPS -15.7%; net margin vs year-ago (~19.6%) is lower.

Cash Flow Quality

Neutral

Net income is positive and supported dividends; dividend payout ratio fell to ~38% (from ~54–60% earlier in 2025), suggesting less pressure. Buybacks/cash flow specifics were not provided.

Leverage & Balance Sheet

Fair

Total assets are stable (~$57–59B), but equity declined (about $15.3B to $14.8B) and net debt increased ($18.8B to $20.8B), indicating somewhat softer leverage metrics.

Shareholder Returns

Fair

Dividend yield is low (~0.52%). Total return cannot be fully assessed because market price-performance inputs (1y/6m/YTD) were not provided; valuation improvement helps, but momentum is unknown.

Analyst Sentiment & Valuation

Positive

Valuation appears more attractive than earlier quarters: P/E compressed to ~18.3 from ~27.5 (2025-12) and consensus target (~$206.75) is slightly above the (not provided) current context.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Marsh delivered a strong Q1 2026 with revenue up 8% to $7.6B and adjusted EPS of $3.29 (+8% YoY), despite significant macro headwinds from lower interest rates and continued P&C/reinsurance pricing declines. Operating margin was resilient: adjusted operating margin held at 31.8%, while RIS margin rose 10 bps to 38.3% and Consulting margin expanded 40 bps to 21.6%, supporting management’s view that margin expansion will continue—especially in 2H 2026. Capital returns were active, with $750M buybacks in the quarter, alongside $5B expected 2026 capital deployment and a $24.5%–25.5% tax-rate outlook. Strategy execution centered on Thrive savings ($400M target; ~$500M charges) and aggressive AI-enabled productivity through BCS automation. Management also addressed AI disintermediation directly, arguing their advantage is trusted advisory plus proprietary data/analytics that speed up application launches (e.g., renewal/captives companions) and improve advocacy outcomes (Claims IQ). Key risks include pricing pressure, interest-rate drag, and ongoing Greenfield litigation ($425M charge).

AI IconGrowth Catalysts

  • RIS growth despite pricing pressure: Marsh Risk revenue +8% YoY (4% underlying), with sequential improvement
  • AI-enabled productivity/efficiency: document ingestion handling thousands of documents weekly, improving process efficiency by ~20%
  • Risk analytics commercialization path: new “Marsh Risk cortex” feeding renewal companion and captives companion launching in a couple of weeks at RINs
  • Claims IQ scale expansion: AI analysis supporting decisions using thousands of colleagues and almost $200B of loss information

Business Development

  • Announced acquisition of AltamarCAM (private market asset manager) with ~ $20B AUM; regulatory approval pending with expected close later in 2026
  • M&A activity referenced: meaningful MMA deal in Hawaii (Q4 prior year); closed sale of an admin business in the Pacific (reported in the quarter)
  • New product deployments referenced in AI tool suite: evolution of Centrus/Blue into “Marsh Risk companion” and AI-driven “renewal companion”/“captives companion” tied to the Risk cortex

AI IconFinancial Highlights

  • Consolidated revenue +8% YoY to $7.6B; underlying revenue +4% (headwinds: lower fiduciary interest income and continued downward P&C pricing pressure)
  • Adjusted EPS $3.29, +8% YoY; adjusted operating income +8% YoY; adjusted operating margin unchanged at 31.8%
  • RIS adjusted operating margin 38.3%, +10 bps YoY; RIS adjusted operating income +7% YoY
  • Consulting adjusted operating margin 21.6%, +40 bps YoY; Consulting revenue +11% YoY (+5% underlying)
  • Fiduciary interest income $85M in Q1, down $18M YoY; Q2 expectation approximately $80M
  • Adjusted effective tax rate 25.1% in Q1 vs 23.1% YoY (prior year benefited from discrete items); 2026 adjusted tax guidance 24.5% to 25.5%
  • Thrive program: total savings target $400M; costs to generate savings approx. $500M; Q1 notable items $521M including $37M Thrive costs and $425M litigation charge related to Greenfield Capital collapse

AI IconCapital Funding

  • Share repurchase $750M in Q1 2026
  • Total debt $20.6B at quarter-end; next scheduled maturity: $550M euro-denominated senior notes in Q3
  • Cash position $1.6B at quarter-end
  • Cash uses in quarter $1.3B: $440M dividends, $89M acquisitions, $750M buybacks
  • Capital deployment expectation: deploy ~ $5B in 2026 across dividends, acquisitions, and share repurchases (buyback level tied to M&A pipeline)

AI IconStrategy & Ops

  • BCS (business and client services) scaling AI automation: consolidating back-office operations/technology into scalable centers to accelerate AI process reengineering
  • AI modernization: reducing cost/time for upgrading code; example legacy tool converted to newly designed broker workbench in days (vs months of effort)
  • Agentic AI in IT help desk reduced inquiries and improved colleague experience; policy renewal center transformed an email-heavy process into a streamlined digital solution in weeks (vs many months)
  • Product/analytics engine: Marsh Risk cortex built to launch applications faster; Risk cortex powers renewal companion/captives companion and supports rapid application launch velocity

AI IconMarket Outlook

  • 2026 underlying revenue growth expected to be similar to 2025
  • Margin expansion and solid adjusted EPS growth expected; greater margin expansion in 2H 2026 than 1H
  • 2026 effective tax rate guidance: 24.5% to 25.5%
  • Q2 fiduciary interest income expected approx. $80M
  • Competitive pricing backdrop cited: primary commercial insurance rates down 5% in Q1 (large-account index); global property rates down 9% YoY

AI IconRisks & Headwinds

  • Lower interest rates driving fiduciary interest income decline (Q1 $85M, down $18M YoY; Q2 expected $80M)
  • Downward pricing pressure across insurance and reinsurance markets (primary rates down 5% in Q1; global property rates down 9% YoY; cat reinsurance non-loss impacted accounts down 15% to 20% for renewals)
  • AI disintermediation concern: management explicitly addressed the risk, arguing AI is embedded in digitization and trusted advisory/data advantage rather than wholesale replacement
  • Ongoing litigation: $425M Greenfield Capital-related charge in Q1; litigation remains unresolved and limits further comment
  • Geopolitical risk (Middle East conflict): expected business impact limited, but risk escalation could increase uncertainty (noted as primarily a “gating issue” tied to escalation; marine war risks may see price spikes)

Q&A: Analyst Interest

  • Topic: Future margin expansion durability + AI disintermediation risk: Management re-affirmed guidance to 19th consecutive margin expansion year in 2026 and framed AI as digitization/efficiency, not broker replacement. They highlighted business scale, proprietary data/models, and trusted client relationships as defenses against disintermediation, citing multiple early-stage AI productivity uses.
  • Topic: Capital allocation amid lower stock/possible valuation changes: Management said capital strategy remains balanced—invest organically/inorganically while targeting annual dividend growth. They cited $750M buybacks in Q1, ~$5B total capital deployment expectation for 2026, and reiterated buybacks depend on M&A pipeline, noting bid-ask gaps and more aggressive financial sponsors.
  • Topic: Claims Advocacy Group value + proof points from AI tools: Management stressed policy drafting/contract certainty prevents rejected claims, then advocacy supports complex losses. They provided stats: Claims IQ uses thousands of colleagues analyzing almost $200B of loss information, and pilots using coverage gap/quote comparison drove 50% higher sales velocity, expecting scalability.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the MMC Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for MMC.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (MMC)

© 2026 Stock Market Info — Marsh & McLennan Companies, Inc. (MMC) Financial Profile